Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in


February 2013
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
15 Jan 2013 - 21 Feb 2013
LC/MS Fundamentals and Applications
3rd Annual Life Science Chief Executive Officer Forum
31 Jan 2013 - 01 Feb 2013
Florida, USA
3rd Annual Life Science Chief Executive Officer Forum
06 Feb 2013 - 08 Feb 2013
• Caesar's Palace • Las Vegas, NV
17th Annual Drug Delivery Partnerships
Parallel Trade
06 Feb 2013 - 07 Feb 2013
London, UK
Parallel Trade
2nd Annual Medical Communications and the Dissemination of Scientific Information Conference
21 Feb 2013 - 22 Feb 2013
Boston, MA, USA
2nd Annual Medical Communications and the Dissemination of Scientific Information Conference
5th Digital Pharma Europe
25 Feb 2013 - 27 Feb 2013
Paris, France
5th Digital Pharma Europe
3rd Patient Adherence and Advocacy Summit
25 Feb 2013 - 26 Feb 2013
3rd Patient Adherence and Advocacy Summit
Medical Device Value Communication Summit
25 Feb 2013 - 26 Feb 2013
San Diego, USA
Medical Device Value Communication Summit
Pharma Packaging & Labelling USA
26 Feb 2013 - 27 Feb 2013
Pharma Packaging & Labelling USA
<< 1 2 >>

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos